OTRIVEN 0.1% dosing spray without conserv

Instructions for use for OTRIVEN 0.1% dosing spray without conserv

Detailed instructions for OTRIVEN 0.1% dosing spray without conserv

Field of use

Otriven Against runny nose 0.1 % nasal spray (dosing spray) without preservatives, the nose frees the nose after 2 minutes and not only has a quick, but also long -lasting. Because Otriven contains the proven active ingredient xylometazoline, which is used to swell the nasal mucosa.
Otriven Against runny nose 0.1 % nasal spray (dosing spray) without preservatives offers help with runny nose and allergic runny nose and can also be used to facilitate the secretion of secretion in the event of an sinus inflammation.

Otriven against runny nose 0.1 % nasal spray (dosing spray) without preservatives is suitable for adults and adolescents over 12 years. For children between 2 and 6 years and for infants, Otriven is also available lower.

Good to know: Otriven against runny nose 0.1 % is also in other dosage formsn (e.g. as a nasal drop or single nose pipettes) available.

Your advantages at an overview

• Free the nose after only 2 minutes
• Has a quick and long -lasting effect

Otriven against runny nose 0.1 % nasal spray (dosing spray) is suitable for the following areas of application:

• To swell the nasal mucosa with a runny nose
• To swell the nasal mucosa when the fluid sniffing and allergic runny nose occur in the case of seeping
• To make the secretion outflow easier for an sinus inflammation and in the case of catarrh of the tube agent in connection with runny nose

Mode of action

The active ingredient xylometazolinhydrochloride contained in Otriven against runny nose 0.1% nasal spray (pack size: 10 ml) has vascular properties by collecting the veins of the mucous membrane. This reduces the excessive blood flow to the nose, which will keep the mucous membrane over.

Active ingredients / ingredients / ingredients

Otriven against runny nose 0.1% nasal spray (dosing spray) (pack size: 10 ml) contains:

1 mg/ml xylometazolin hydrochloride, cleaned water; Natrumchloride; Sodium monohydrogen phosphate-dodecahydrate; Sodium dihydrogen phosphate dihydrate; Sodium defeat.

Contradictions

In the case of known hypersensitivity to the active ingredient, in children under 6 years, green star and when drying out the nasal mucosa with bark formation Otriven against a cold 0.1% nasal spray (dosing spray) (pack size: 10 ml) be applied. During pregnancy and breastfeeding, cardiovascular diseases, metabolic diseases, taking blood pressure-enhancing medicines, increased intraocular pressure, genetically determined disturbance of parts of the red blood pigment (porphyria) and with benign enlargement of the contestation gland is a doctor before using this product to consult.

dosage

Application recommendation of Otriven against runny nose 0.1% nasal spray (dosing spray) (pack size: 10 ml):

When using Otriven Pumping against runny nose 0.1% nasal spray (dosing spray) (package size: 10 ml) strong several times until a fine spray is created. Before using Otriven against runny nose 0.1% nasal spray (dosing spray) (pack size: 10 ml) by rolling hard. Unless otherwise prescribed, adults and adolescents over 12 years of age spray up to 3 times a day 1 spray Otriven against runny nose 0.1% nasal spray (dosing spray) (pack size: 10 ml) in each Nasal opening. Breathe in the nose slightly during the spray process. Wipe the nose tube carefully after use to avoid a virus accumulation. Ideally, the last application of the day should take place before going to sleep.

Taking

• This preparation is intended for nasal application.
• It is advisable to thoroughly roll your nose before using the preparation.
• The last application on every treatment day should be done cheaply before going to bed.
• For hygienic reasons and to avoid infections, it is pointed out that each dosing unit may only be used by one patient.

Patient information

• Special care in the application is required
  • In the following illnesses and situations, you may only use the medicine after consultation with your doctor:
    • with an increased intraocular pressure, especially narrow -angle glaucoma
    • severe cardiovascular diseases (e.g. coronary heart disease) and high blood pressure (hypertension)
    • if they are treated with monoaminooxidase inhibitors (MAO inhibitors) and other potentially blood pressure-enhancing medicines
    • Tumor of the adrenal gland (Phäochromocytom)
    • Fabricversions, such as B. Overactive thyroid gland (hyperthyroidism) and diabetes (diabetes mellitus)
    • Prostate enlargement
    • Metabolic disease (porphyria)
    • The permanent use of drugs swelling of mucosa can lead to chronic swelling and finally to the loss of the nasal mucosa.
  • What should be taken into account in children and the elderly?
    • The drug must not be used in children under 6 years.

 

• Wateriness and operating machines
  • No impairments can be expected in the event of intended use.

Pregnancy

• Since the security of an application of this drug during pregnancy and breastfeeding is not sufficiently proven, you may only take it on the advice of your doctor and only after this has carried out careful benefits/risk assessment. During pregnancy and breastfeeding, the recommended dosage must not be exceeded, since overdose can affect blood supply to the unborn child or reduce milk production.

Hints

Otriven against runny nose 0.1% nasal spray (dosing spray) (pack size: 10 ml) contains no preservatives. If possible, no alcohol should be drunk while using this product. For hygienic reasons and to avoid virus transmission, spray bottle should only be used by one and the same person.

Miscellaneous

- In the case of longer use or higher amounts of the drug, effects with effects on the heart and vessels or effects on the brain and spinal cord cannot be excluded. In these cases, the ability to carry a motor vehicle and to operate machines can be impaired.- Prolonged or frequent use as well as higher amounts of the medicine can burn in the nose or dryness of the mucosa as well as, especially with longer use and overdose, increased blood circulation the nasal mucosa come. This effect leads to a narrowing of the air routes, with the result that the medicine is used repeatedly up to permanent use. The result is chronic swellings (rhinitis medicamentosa) up to the atrophy of the nasal mucosa (stinnnut). This effect can occur after 5-7-day treatment and, after continued application, cause permanent mucosal compensation with bark formation (rhinitis sicca) .- A new application should only take place after a break of several days. to be discontinued on a nostril and switch to the other side after the complaints have subsided in order to maintain at least part of the nasal breathing.

Manufacturer:  Glaxosmithklin Consumer Healthc, Barthstraße 4, 80339 Munich